CTI Life Sciences Fund

company

About

CTI makes venture capital investments mostly in biotech companies at the pre-clinical and clinical development stages.

  • 1 - 10

Highlights

Details

Industries
Clinical Trials,Life Science,Venture Capital
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.

Investments

Number of Investments
Number of Lead Investments
3
0
CTI Life Sciences Fund has made 3 investments. Their most recent investment was on Apr 25, 2022, when Epitopea raised £10.30M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 25, 2022 Epitopea
Seed £10.30M Biotechnology
Jan 8, 2016 Zymeworks
Series A $61.50M Biotechnology
Jan 13, 2015 Zymeworks
Series Unknown $23.98M Biotechnology